Photonics
-
DATABASE (5)
-
ARTICLES (2)
iLoF creates a digital library of optical fingerprints for non-invasive patient screening, early diagnostics and personalized medical treatments.
iLoF creates a digital library of optical fingerprints for non-invasive patient screening, early diagnostics and personalized medical treatments.
Samsung Venture Investment, or Samsung Ventures, is the VC investment arm of South Korean diversified conglomerate Samsung Group. It is a separate entity from Samsung NEXT.Samsung Ventures primarily invests in semiconductors, telecommunications tech, software and internet companies, as well as biotechnology and medical companies. The VC is built to support new innovations that can lead to further improvements in Samsung’s existing businesses, which includes smartphones, home appliances, and components like OLED panels and Li-ion batteries.Samsung Ventures has invested in healthcare and wellness tech companies like Indonesia’s telehealth service Alodokter, posture correction device makers Posture360, and Noom, an app for dieting and exercise. In the sensors front, Samsung Ventures has invested in Sense Photonics, a startup creating 3D computer vision based on lidar for industrial and automotive (self-driving) purposes. Besides these companies, Samsung Ventures has also invested in insurtech companies and even gaming companies, such as Pokémon Go developer Niantic.
Samsung Venture Investment, or Samsung Ventures, is the VC investment arm of South Korean diversified conglomerate Samsung Group. It is a separate entity from Samsung NEXT.Samsung Ventures primarily invests in semiconductors, telecommunications tech, software and internet companies, as well as biotechnology and medical companies. The VC is built to support new innovations that can lead to further improvements in Samsung’s existing businesses, which includes smartphones, home appliances, and components like OLED panels and Li-ion batteries.Samsung Ventures has invested in healthcare and wellness tech companies like Indonesia’s telehealth service Alodokter, posture correction device makers Posture360, and Noom, an app for dieting and exercise. In the sensors front, Samsung Ventures has invested in Sense Photonics, a startup creating 3D computer vision based on lidar for industrial and automotive (self-driving) purposes. Besides these companies, Samsung Ventures has also invested in insurtech companies and even gaming companies, such as Pokémon Go developer Niantic.
CSO and co-founder of iLoF
Paula Sampaio is a biochemist who completed a PhD in biomedical sciences at the University of Porto in 1998. She worked as a postdoctoral research fellow at the IMBC INEB Associate Laboratory for four years. In 2002, she was promoted to the role of head of advanced light microscopy and stayed there until 2015. Sampaio is now the national coordinator for Portuguese bioimage platform PPBI and the head of advanced light microscopy at the Institute of Research and Innovation of the University of Porto (i3S).In November 2019, she joined iLoF as CSO and co-founder. iLoF gets technical support from i3S at the R&D center in Porto. The medtech startup focuses on personalized medicine through the use of AI and photonics to create optical fingerprints in a cloud-based library to gather and manages disease biomarkers and biological profiles.
Paula Sampaio is a biochemist who completed a PhD in biomedical sciences at the University of Porto in 1998. She worked as a postdoctoral research fellow at the IMBC INEB Associate Laboratory for four years. In 2002, she was promoted to the role of head of advanced light microscopy and stayed there until 2015. Sampaio is now the national coordinator for Portuguese bioimage platform PPBI and the head of advanced light microscopy at the Institute of Research and Innovation of the University of Porto (i3S).In November 2019, she joined iLoF as CSO and co-founder. iLoF gets technical support from i3S at the R&D center in Porto. The medtech startup focuses on personalized medicine through the use of AI and photonics to create optical fingerprints in a cloud-based library to gather and manages disease biomarkers and biological profiles.
CTO and co-founder of iLoF
Joana Paiva graduated in 2014 with a master’s in biomedical engineering at the University of Coimbra in Portugal. She went on to complete a PhD in physics at the University of Porto in 2019.In 2014, she also worked at INESC Technology and Science for almost five years while completing her PhD thesis: Intelligent Lab on Fiber tools for sensing single-cells and extracellular nano-vesicles. It was her research that led to the founding of medtech startup iLoF.In August 2019, she co-founded iLoF as CTO. The Oxford-Oporto-based startup enables personalized medicine through the use of AI and photonics to create optical fingerprints in a cloud-based library to collate disease biomarkers and biological profiles.Based in Porto, she is also a co-inventor with three patents and 29 scientific publications. She is one of Forbes 30 Under 30 for science and healthcare and was nominated for the EIT Woman Award 2020.
Joana Paiva graduated in 2014 with a master’s in biomedical engineering at the University of Coimbra in Portugal. She went on to complete a PhD in physics at the University of Porto in 2019.In 2014, she also worked at INESC Technology and Science for almost five years while completing her PhD thesis: Intelligent Lab on Fiber tools for sensing single-cells and extracellular nano-vesicles. It was her research that led to the founding of medtech startup iLoF.In August 2019, she co-founded iLoF as CTO. The Oxford-Oporto-based startup enables personalized medicine through the use of AI and photonics to create optical fingerprints in a cloud-based library to collate disease biomarkers and biological profiles.Based in Porto, she is also a co-inventor with three patents and 29 scientific publications. She is one of Forbes 30 Under 30 for science and healthcare and was nominated for the EIT Woman Award 2020.
COO and co-founder of iLoF
Mehak Mumtaz grew up in Pakistan and decided to study biochemistry when she saw her brother suffering from an unknown learning disability. Her parents, both medical doctors, could not get an accurate diagnosis for their son. In her search to understand the molecular mechanisms behind diseases, she applied to study at the University of Oxford. In 2008, she was granted the Reach Oxford Scholarship and graduated with a master’s in biochemistry in 2012. In 2015, the St Hilda’s alumna worked as an undergraduate tutor at Oxford while completing a PhD in pathology, specializing in oncology and cancer biology.In 2018, she worked on a rare cancer project as EIT Health Business Innovation fellow for a year. She left academia and joined a three-month bioentrepreneur bootcamp in Munich and a one-month Lev8 Woman Program at her alma mater’s Oxford Foundry. She joined EY-Parthenon in London as a strategy consultant in April 2019.In 2019, Mumtaz also met the iLoF co-founding team at the EIT Health Wild Card venture-building program. iLoF is a medtech startup that focuses on personalized medicine through the use of AI and photonics to create optical fingerprints in a cloud-based library to gather and manages disease biomarkers and biological profiles.She joined iLoF as COO and co-founder in December 2019 and left her full-time consultancy role at EY in March 2020.
Mehak Mumtaz grew up in Pakistan and decided to study biochemistry when she saw her brother suffering from an unknown learning disability. Her parents, both medical doctors, could not get an accurate diagnosis for their son. In her search to understand the molecular mechanisms behind diseases, she applied to study at the University of Oxford. In 2008, she was granted the Reach Oxford Scholarship and graduated with a master’s in biochemistry in 2012. In 2015, the St Hilda’s alumna worked as an undergraduate tutor at Oxford while completing a PhD in pathology, specializing in oncology and cancer biology.In 2018, she worked on a rare cancer project as EIT Health Business Innovation fellow for a year. She left academia and joined a three-month bioentrepreneur bootcamp in Munich and a one-month Lev8 Woman Program at her alma mater’s Oxford Foundry. She joined EY-Parthenon in London as a strategy consultant in April 2019.In 2019, Mumtaz also met the iLoF co-founding team at the EIT Health Wild Card venture-building program. iLoF is a medtech startup that focuses on personalized medicine through the use of AI and photonics to create optical fingerprints in a cloud-based library to gather and manages disease biomarkers and biological profiles.She joined iLoF as COO and co-founder in December 2019 and left her full-time consultancy role at EY in March 2020.
iLoF: Accelerating access to personalized medicine, from a drop of blood
Backed by Microsoft’s venture fund M12, Mayfield and Melinda Gates’s Pivotal Ventures, iLoF focuses on painless screening to facilitate disease detection, forecasting and drug development, from Alzheimer’s to Covid-19
Its latest project, Cattlechain, is an IoT-blockchain solution for farms to meet the EU's animal welfare standards, fulfilling consumers' demand for sustainable farming and food traceability
Sorry, we couldn’t find any matches for“Photonics”.
POPULAR DATABASE
